Starvation and Pseudo-Starvation as Drivers of Cancer Metastasis through Translation Reprogramming
Open accessThe DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Abstract
Summary Considerable progress has been made in identifying microenvironmental signals that effect the reversible phenotypic transitions underpinning the early steps in the metastatic cascade. However, although the general principles underlying metastatic dissemination have been broadly outlined, a common theme that unifies many of the triggers of invasive behavior in tumors has yet to emerge. Here we discuss how many diverse signals that induce invasion converge on reprogramming of protein translation via phosphorylation of eIF2α, a hallmark of the starvation response. These include starvation as a consequence of nutrient or oxygen limitation, or pseudo-starvation imposed by cell extrinsic microenvironmental signals or by cell intrinsic events including oncogene activation. Since in response to resource limitation single cell organisms undergo phenotypic transitions remarkably similar to those observed within tumors, we propose that a starvation/pseudo-starvation model to explain cancer progression provides an integrated and evolutionarily conserved conceptual framework to understand progression of this complex disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21332 · Cited by 16,003 · cited 1×
“If the probability of a cancer cell adopting an invasive phenotype is a stochastic process that ultimately depends on its sensitivity to microenvironmental cues, then what are the signals that drive the transition to invasiveness? Or more simply put, why does any cell move? Understanding the reason why proliferating c…”
BackgroundMicroenvironmental regulation of tumor progression and metastasis
Quail, D. F., & Joyce, J. A. (2013) · Nature Medicine · doi:10.1038/nm.3394 · Cited by 7,994 · cited 22×
“Identification of the tumour transition states occurring during EMT.”
BackgroundInfluentialVogelstein, B., Papadopoulos, N., Velculescu, V. E., Zhou, S., Diaz, L. A., & Kinzler, K. W. (2013) · Science · doi:10.1126/science.1235122 · Cited by 7,863 · cited 1×
“As proposed previously (Vogelstein et al., 2013), metastasis may therefore be a stochastic process in which genetic lesions confer sensitivity to changes in the microenvironment leading to phenotypic instability (Hoek and Goding, 2010).”
BackgroundmTOR Signaling in Growth, Metabolism, and Disease
Saxton, R. A., & Sabatini, D. M. (2017) · Cell · doi:10.1016/j.cell.2017.02.004 · Cited by 7,555
The emerging hallmarks of cancer metabolism
Pavlova, N. N., & Thompson, C. B. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.006 · Cited by 5,926 · cited 3×
“Strategies that increase supply include: metabolic adaptation to use alternative fuels, including glucose, glutamine, alanine, pyruvate, lactate and lipids (Allen et al., 2016; Jimenez-Valerio and Casanovas, 2016; Nieman et al., 2011; Pavlova and Thompson, 2016; Pisarsky et al., 2016); increased macropinocytosis to ta…”
BackgroundJaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535 · cited 2×
“…include: metabolic adaptation to use alternative fuels, including glucose, glutamine, alanine, pyruvate, lactate and lipids (Allen et al., 2016; Jimenez-Valerio and Casanovas, 2016; Nieman et al., 2011; Pavlova and Thompson, 2016; Pisarsky et al., 2016); increased macropinocytosis to take up…”
BackgroundHIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735 · cited 3×
“A uthor M anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript hydroxylases FIH (Factor Inhibiting Hypoxia-induced factor) (Mahon et al., 2001) and VHL (Von Hippel-Lindau) (Ivan et al., 2001; Jaakkola et al., 2001) and stabilization of the hypoxia-inducible factors HIF1α, HIF1β and HIF2.”
BackgroundNieto, M. A., Huang, R. Y.-J., Jackson, R. A., & Thiery, J. P. (2016) · Cell · doi:10.1016/j.cell.2016.06.028 · Cited by 4,492 · cited 23×
“Identification of the tumour transition states occurring during EMT.”
BackgroundInfluentialMutational landscape and significance across 12 major cancer types
Kandoth, C., McLellan, M. D., Vandin, F., Ye, K., Niu, B., Lu, C., Xie, M., Zhang, Q., McMichael, J. F., Wyczalkowski, M. A., et al. (2013) · Nature · doi:10.1038/nature12634 · Cited by 4,419
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088 · cited 1×
“of it being used to fuel anabolic metabolism (Altman et al., 2016; DeBerardinis et al., 2008; Wise and Thompson, 2010).”
MethodGenomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
Hugo, W., Zaretsky, J. M., Sun, L., Song, C., Moreno, B. H., Hu-Lieskovan, S., Berent-Maoz, B., Pang, J., Chmielowski, B., Cherry, G., et al. (2016) · Cell · doi:10.1016/j.cell.2016.02.065 · Cited by 3,448 · cited 1×
“, 2009a; Rosen and Jordan, 2009; Shackleton, 2010; Visvader and Lindeman, 2008) or resistance to targeted therapies, including immune checkpoint inhibitors (Emmons et al., 2016; Holzel et al., 2013; Hugo et al., 2016; Rambow et al., 2018; Smith and Bhowmick, 2016; Tsoi et al., 2018).”
BackgroundMetabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
Chang, C.-H., Qiu, J., O’Sullivan, D., Buck, M. D., Noguchi, T., Curtis, J. D., Chen, Q., Gindin, M., Gubin, M. M., van der Windt, G. J. W., et al. (2015) · Cell · doi:10.1016/j.cell.2015.08.016 · Cited by 3,331 · cited 2×
“Similarly, the high glycolytic activity of many tumors can trigger glucose limitation within the tumor microenvironment leading to metabolic restriction of tumor-associated T-cells (Chang et al., 2015).”
BackgroundMetabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
Ward, P. S., & Thompson, C. B. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.014 · Cited by 3,233 · cited 2×
“Instructions to divide are provided by mitogens and growth factors that act through their receptors and downstream signaling pathways to drive cell division, reprogram the Rb-E2F1 axis that maintains quiescence (Yao, 2014), and increase uptake of nutrients necessary to sustain growth and proliferation (Ward and Thomps…”
BackgroundThe Rag GTPases Bind Raptor and Mediate Amino Acid Signaling to mTORC1
Sancak, Y., Peterson, T. R., Shaul, Y. D., Lindquist, R. A., Thoreen, C. C., Bar-Peled, L., & Sabatini, D. M. (2008) · Science · doi:10.1126/science.1157535 · Cited by 2,773 · cited 3×
“PTEN Deficiency and AMPK Activation Promote Nutrient Scavenging and Anabolism in Prostate Cancer Cells.”
BackgroundThe integrated stress response
Pakos‐Zebrucka, K., Koryga, I., Mnich, K., Ljujic, M., Samali, A., & Gorman, A. M. (2016) · The EMBO Reports · doi:10.15252/embr.201642195 · Cited by 2,659
IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z.-W., Egan, L. J., Kagnoff, M. F., & Karin, M. (2004) · Cell · doi:10.1016/j.cell.2004.07.013 · Cited by 2,433
The causes and consequences of genetic heterogeneity in cancer evolution
Burrell, R. A., McGranahan, N., Bartek, J., & Swanton, C. (2013) · Nature · doi:10.1038/nature12625 · Cited by 2,262
EMT and Dissemination Precede Pancreatic Tumor Formation
Rhim, A. D., Mirek, E. T., Aiello, N. M., Maitra, A., Bailey, J. M., McAllister, F., Reichert, M., Beatty, G. L., Rustgi, A. K., Vonderheide, R. H., et al. (2012) · Cell · doi:10.1016/j.cell.2011.11.025 · Cited by 2,136 · cited 1×
“Indeed, in a mouse model of pancreatic cancer, for example, inflammation was closely associated with cancer cell dissemination that occurred even prior to primary tumor formation (Rhim et al., 2012).”
BackgroundFrom Krebs to clinic: glutamine metabolism to cancer therapy
Altman, B. J., Stine, Z. E., & Dang, C. V. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.71 · Cited by 2,119
Metastatic colonization by circulating tumour cells
Massagué, J., & Obenauf, A. C. (2016) · Nature · doi:10.1038/nature17038 · Cited by 2,062 · cited 1×
“, 2000; Kang and Pantel, 2013), but few survive and fewer are competent to form metastases (Cameron et al., 2000; Lambert et al., 2017; Luzzi et al., 1998; Massague and Obenauf, 2016; Vanharanta and Massague, 2013).”
BackgroundGlutamine addiction: a new therapeutic target in cancer
Wise, D. R., & Thompson, C. B. (2010) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2010.05.003 · Cited by 1,770
ER-stress-induced transcriptional regulation increases protein synthesis leading to cell death
Han, J., Back, S. H., Hur, J., Lin, Y.-H., Gildersleeve, R., Shan, J., Yuan, C. L., Krokowski, D., Wang, S., Hatzoglou, M., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2738 · Cited by 1,691
Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells
Commisso, C., Davidson, S. M., Soydaner-Azeloglu, R. G., Parker, S. J., Kamphorst, J. J., Hackett, S., Grabocka, E., Nofal, M., Drebin, J. A., Thompson, C. B., et al. (2013) · Nature · doi:10.1038/nature12138 · Cited by 1,683
Inflammation and wound healing: the role of the macrophage
Koh, T. J., & DiPietro, L. A. (2011) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399411001943 · Cited by 1,667 · cited 1×
“Tumor necrosis factor alpha (TNFα), a primary inflammatory cytokine, is frequently found at high levels in tumors (Balkwill, 2009) and in wound healing (Koh and DiPietro, 2011) primarily as a result of secretion by infiltrating immune cells.”
BackgroundMechanisms and regulation of endothelial VEGF receptor signalling
Simons, M., Gordon, E., & Claesson-Welsh, L. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.87 · Cited by 1,498 · cited 1×
“Tumor cells may also ensure a longer-term increase in nutrient supply by stimulating neo-angiogenesis through the expression of Vascular Endothelial Growth Factor (VEGF) that promotes formation of new blood vessels (Simons et al., 2016).”
BackgroundPancreatic cancers require autophagy for tumor growth
Yang, S., Wang, X., Contino, G., Liesa, M., Sahin, E., Ying, H., Bause, A., Li, Y., Stommel, J. M., Dell'Antonio, G., et al. (2011) · Genes & Development · doi:10.1101/gad.2016111 · Cited by 1,498
Mahon, P. C., Hirota, K., & Semenza, G. L. (2001) · Genes & Development · doi:10.1101/gad.924501 · Cited by 1,385 · cited 1×
“hydroxylases FIH (Factor Inhibiting Hypoxia-induced factor) (Mahon et al., 2001) and VHL (Von Hippel-Lindau) (Ivan et al.”
Rankin, E. B., & Giaccia, A. J. (2016) · Science · doi:10.1126/science.aaf4405 · Cited by 1,340 · cited 1×
“in metastasis including intra- and extravasation (Rankin and Giaccia, 2016; Semenza, 2016), triggers”
BackgroundHIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations
Semenza, G. L. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67230 · Cited by 1,335 · cited 1×
“Increased HIF activity mediates an adaptive response to hypoxia directed towards promoting survival including metabolic reprogramming, regulation of microenvironmental pH and up-regulation of VEGF expression to promote new blood vessel formation (Marchiq and Pouyssegur, 2016; Semenza, 2013,2015.”
BackgroundActivated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis
Guo, J. Y., Chen, H.-Y., Mathew, R., Fan, J., Strohecker, A. M., Karsli-Uzunbas, G., Kamphorst, J. J., Chen, G., Lemons, J. M. S., Karantza, V., et al. (2011) · Genes & Development · doi:10.1101/gad.2016311 · Cited by 1,323
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance
Shaffer, S. M., Dunagin, M. C., Torborg, S. R., Torre, E. A., Emert, B., Krepler, C., Beqiri, M., Sproesser, K., Brafford, P. A., Xiao, M., et al. (2017) · Nature · doi:10.1038/nature22794 · Cited by 1,218 · cited 1×
“For example, recent characterization of single melanoma cells within tumors revealed a subset of rare, phenotypically distinct, cells that exhibited a transient transcriptional state that conferred resistance to BRAF inhibitors (Shaffer et al., 2017).”
BackgroundBrafV600E cooperates with Pten loss to induce metastatic melanoma
Dankort, D., Curley, D. P., Cartlidge, R. A., Nelson, B., Karnezis, A. N., Damsky Jr, W. E., You, M. J., DePinho, R. A., McMahon, M., & Bosenberg, M. (2009) · Nature Genetics · doi:10.1038/ng.356 · Cited by 1,189
The eIF2α/ATF4 pathway is essential for stress-induced autophagy gene expression
B’chir, W., Maurin, A.-C., Carraro, V., Averous, J., Jousse, C., Muranishi, Y., Parry, L., Stepien, G., Fafournoux, P., & Bruhat, A. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt563 · Cited by 1,162
Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion
Sousa, C. M., Biancur, D. E., Wang, X., Halbrook, C. J., Sherman, M. H., Zhang, L., Kremer, D., Hwang, R. F., Witkiewicz, A. K., Ying, H., et al. (2016) · Nature · doi:10.1038/nature19084 · Cited by 1,122
Biological and therapeutic impact of intratumor heterogeneity in cancer evolution
McGranahan, N., & Swanton, C. (2015) · Cancer Cell · doi:10.1016/j.ccell.2014.12.001 · Cited by 1,077 · cited 2×
“Genetic (Kandoth et al., 2013; McGranahan and Swanton, 2015) and phenotypic (Marusyk and Polyak, 2010) heterogeneity shape cancer progression and represent a considerable barrier to effective therapy (Brooks et al.”
BackgroundHarris, I. S., Treloar, A. E., Inoue, S., Sasaki, M., Gorrini, C., Lee, K. C., Yung, K. Y., Brenner, D., Knobbe-Thomsen, C. B., Cox, M. A., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2014.11.019 · Cited by 993
Tsoi, J., Robert, L., Paraiso, K., Galvan, C., Sheu, K. M., Lay, J., Wong, D. J. L., Atefi, M., Shirazi, R., Wang, X., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.017 · Cited by 938 · cited 1×
“, 2009a; Rosen and Jordan, 2009; Shackleton, 2010; Visvader and Lindeman, 2008) or resistance to targeted therapies, including immune checkpoint inhibitors (Emmons et al., 2016; Holzel et al., 2013; Hugo et al., 2016; Rambow et al., 2018; Smith and Bhowmick, 2016; Tsoi et al., 2018).”
BackgroundKamphorst, J. J., Nofal, M., Commisso, C., Hackett, S. R., Lu, W., Grabocka, E., Vander Heiden, M. G., Miller, G., Drebin, J. A., Bar-Sagi, D., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2211 · Cited by 893
Contextual determinants of TGFβ action in development, immunity and cancer
David, C. J., & Massagué, J. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0007-0 · Cited by 851 · cited 1×
“…of SMADs may lead to context-specific patterns of gene expression resulting from cooperative binding with lineage specific transcription factors (David and Massague, 2018), TGFβ signaling can lead to up-regulation of a repertoire of chemokines and signaling molecules, including VEGF (Feng et…”
BackgroundTranscriptional control of autophagy-lysosome function drives pancreatic cancer metabolism
Perera, R. M., Stoykova, S., Nicolay, B. N., Ross, K. N., Fitamant, J., Boukhali, M., Lengrand, J., Deshpande, V., Selig, M. K., Ferrone, C. R., et al. (2015) · Nature · doi:10.1038/nature14587 · Cited by 799
mTORC1 induces purine synthesis through control of the mitochondrial tetrahydrofolate cycle
Ben-Sahra, I., Hoxhaj, G., Ricoult, S. J. H., Asara, J. M., & Manning, B. D. (2016) · Science · doi:10.1126/science.aad0489 · Cited by 795
Toward Minimal Residual Disease-Directed Therapy in Melanoma
Rambow, F., Rogiers, A., Marin-Bejar, O., Aibar, S., Femel, J., Dewaele, M., Karras, P., Brown, D., Chang, Y. H., Debiec-Rychter, M., et al. (2018) · Cell · doi:10.1016/j.cell.2018.06.025 · Cited by 771 · cited 2×
“…Gupta et al., 2009a; Rosen and Jordan, 2009; Shackleton, 2010; Visvader and Lindeman, 2008) or resistance to targeted therapies, including immune checkpoint inhibitors (Emmons et al., 2016; Holzel et al., 2013; Hugo et al., 2016; Rambow et al., 2018; Smith and Bhowmick, 2016; Tsoi et al., 2018).”
BackgroundReparative inflammation takes charge of tissue regeneration
Karin, M., & Clevers, H. (2016) · Nature · doi:10.1038/nature17039 · Cited by 767
Why are tumour blood vessels abnormal and why is it important to know?
Nagy, J. A., Chang, S.-H., Dvorak, A. M., & Dvorak, H. F. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604929 · Cited by 611 · cited 1×
“As tumors grow, the risk of both nutritional and hypoxic stress is enhanced by their frequently chaotic neovasculature (Nagy et al., 2009).”
BackgroundMechanisms Governing Metastatic Dormancy and Reactivation
Giancotti, F. G. (2013) · Cell · doi:10.1016/j.cell.2013.10.029 · Cited by 586 · cited 1×
“Phenotype fixation is consistent with the fact that the majority of the cells that survive dissemination and extravasate to invade surrounding tissues do not readily take up proliferation (Giancotti, 2013; Naumov et al., 2002; Sosa et al., 2014).”
BackgroundVanharanta, S., & Massagué, J. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.09.007 · Cited by 563
PDK1-Dependent Metabolic Reprogramming Dictates Metastatic Potential in Breast Cancer
Dupuy, F., Tabariès, S., Andrzejewski, S., Dong, Z., Blagih, J., Annis, M. G., Omeroglu, A., Gao, D., Leung, S., Amir, E., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.08.007 · Cited by 558
Stress-Induced Mutagenesis in Bacteria
Foster, P. L. (2007) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409230701648494 · Cited by 536 · cited 2×
“…is known of how translation reprogramming might affect genome instability in cancer, in bacteria exposure to nutritional or other stresses leads to increased expression of error-prone DNA polymerases that increase the genetic diversity within the population (Foster, 2007; MacLean et al., 2013).”
BackgroundThe hypoxic tumor microenvironment: A driving force for breast cancer progression
Semenza, G. L. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.05.036 · Cited by 535 · cited 1×
“Similarly, hypoxia, that drives several steps in metastasis including intra- and extravasation (Rankin and Giaccia, 2016; Semenza ,2016) , triggers invasion in breast cancer that is associated with activation of the eIF2α kinase PERK (Nagelkerke et al., 2013).”
BackgroundTumor hypoxia and malignant progression
Vaupel, P., Mayer, A., & Höckel, M. (2004) · Methods in Enzymology · doi:10.1016/s0076-6879(04)81023-1 · Cited by 496 · cited 1×
“For example, poor blood flow in functionally and structurally abnormal vessels can lead to perfusion-limited hypoxia such that even cells close to vessels may be hypoxic while cells at a distance from vessels will be exposed to more severe diffusion-limited hypoxia (Vaupel et al., 2004).”
BackgroundRathmell, J. C., Heiden, M. G. V., Harris, M. H., Frauwirth, K. A., & Thompson, C. B. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00066-6 · Cited by 467 · cited 1×
“Moreover, unlike bacteria or yeast, the presence of an extracellular nutrient supply does not normally trigger proliferation of mammalian cells (Lloyd, 2013; Rathmell et al., 2000).”
BackgroundThe utilization of extracellular proteins as nutrients is suppressed by mTORC1
Palm, W., Park, Y., Wright, K., Pavlova, N. N., Tuveson, D. A., & Thompson, C. B. (2015) · Cell · doi:10.1016/j.cell.2015.06.017 · Cited by 457 · cited 1×
“, 2016); increased macropinocytosis to take up and degrade proteins and lipids from their environment, including extracellular matrix and necrotic cell debris (Commisso et al., 2013; Davidson et al., 2016; Kamphorst et al., 2015; Kim et al., 2018; Muranen et al., 2017; Palm et al., 2015); secretion of ‘feed me’ signal…”
BackgroundTargeting ER stress–induced autophagy overcomes BRAF inhibitor resistance in melanoma
Ma, X.-H., Piao, S.-F., Dey, S., Mcafee, Q., Karakousis, G., Villanueva, J., Hart, L. S., Levi, S., Hu, J., Zhang, G., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci70454 · Cited by 457
Aspartate is a limiting metabolite for cancer cell proliferation under hypoxia and in tumours
Garcia-Bermudez, J., Baudrier, L., La, K., Zhu, X. G., Fidelin, J., Sviderskiy, V. O., Papagiannakopoulos, T., Molina, H., Snuderl, M., Lewis, C. A., et al. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0118-z · Cited by 442
Martinez-Outschoorn, U. E., Lisanti, M. P., & Sotgia, F. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.01.005 · Cited by 423 · cited 1×
“, 2015); secretion of ‘feed me’ signals that trigger release of nutrients including amino and fatty acids from other cells in the vicinity, a process termed metabolic symbiosis (Martinez-Outschoorn et al., 2014; Mikkilineni et al., 2017; Nakajima and Van Houten, 2013; Sonveaux et al., 2008; Sousa et al., 2016); and en…”
BackgroundLloyd, A. C. (2013) · Cell · doi:10.1016/j.cell.2013.08.053 · Cited by 393 · cited 1×
“Moreover, unlike bacteria or yeast, the presence of an extracellular nutrient supply does not normally trigger proliferation of mammalian cells (Lloyd, 2013; Rathmell et al., 2000).”
BackgroundSrivastava, S. P., Kumar, K. U., & Kaufman, R. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.4.2416 · Cited by 378 · cited 7×
“Tumor suppression by PTEN requires the activation of the PKReIF2αlpha phosphorylation pathway.”
BackgroundInfluentialPan, M., Reid, M. A., Lowman, X. H., Kulkarni, R. P., Tran, T. Q., Liu, X., Yang, Y., Hernandez-Davies, J. E., Rosales, K. K., Li, H., et al. (2016) · Nature Cell Biology · doi:10.1038/ncb3410 · Cited by 368 · cited 1×
“Glutamine, the most abundant amino acid in the blood (Brosnan, 2003) can be depleted in tumors (Kamphorst et al., 2015; Pan et al., 2016; Roberts et al., 1956), most likely as a result García-Jiménez and Goding Page 4”
BackgroundDirect evidence for cancer-cell-autonomous extracellular protein catabolism in pancreatic tumors
Davidson, S. M., Jonas, O., Keibler, M. A., Hou, H. W., Luengo, A., Mayers, J. R., Wyckoff, J., Del Rosario, A. M., Whitman, M., Chin, C. R., et al. (2017) · Nature Medicine · doi:10.1038/nm.4256 · Cited by 331
Hypoxia, cancer metabolism and the therapeutic benefit of targeting lactate/H(+) symporters
Marchiq, I., & Pouysségur, J. (2016) · Journal of Molecular Medicine · doi:10.1007/s00109-015-1307-x · Cited by 300 · cited 1×
“Increased HIF activity mediates an adaptive response to hypoxia directed towards promoting survival including metabolic reprogramming, regulation of microenvironmental pH and up-regulation of VEGF expression to promote new blood vessel formation (Marchiq and Pouyssegur, 2016; Semenza, 2013,2015.”
BackgroundAllen, E., Miéville, P., Warren, C. M., Saghafinia, S., Li, L., Peng, M.-W., & Hanahan, D. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.04.029 · Cited by 221 · cited 1×
“Strategies that increase supply include: metabolic adaptation to use alternative fuels, including glucose, glutamine, alanine, pyruvate, lactate and lipids (Allen et al., 2016; Jimenez-Valerio and Casanovas, 2016; Nieman et al., 2011; Pavlova and Thompson, 2016; Pisarsky et al., 2016); increased macropinocytosis to ta…”
BackgroundKim, S. M., Nguyen, T. T., Ravi, A., Kubiniok, P., Finicle, B. T., Jayashankar, V., Malacrida, L., Hou, J., Robertson, J., Gao, D., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-1215 · Cited by 199 · cited 1×
“, 2016); increased macropinocytosis to take up and degrade proteins and lipids from their environment, including extracellular matrix and necrotic cell debris (Commisso et al., 2013; Davidson et al., 2016; Kamphorst et al., 2015; Kim et al., 2018; Muranen et al., 2017; Palm et al., 2015); secretion of ‘feed me’ signal…”
BackgroundCorazzari, M., Rapino, F., Ciccosanti, F., Giglio, P., Antonioli, M., Conti, B., Fimia, G. M., Lovat, P. E., & Piacentini, M. (2015) · Cell Death & Differentiation · doi:10.1038/cdd.2014.183 · Cited by 162 · cited 1×
“Moreover, activation of BRAF in melanocytes can lead to eIF2α phosphorylation (Corazzari et al., 2015; Ferretta et al., 2016) and an E- to N-cadherin switch in adhesion molecules that may prime for invasive behavior (Boyd et al.”
BackgroundTwo phases of disulfide bond formation have differing requirements for oxygen
Koritzinsky, M., Levitin, F., van den Beucken, T., Rumantir, R. A., Harding, N. J., Chu, K. C., Boutros, P. C., Braakman, I., & Wouters, B. G. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201307185 · Cited by 136 · cited 2×
“Phosphorylation on Ser51 of eIF2α, the smallest subunit of the eIF2 translation initiation complex, by GCN2, PRKR-like ER kinase (PERK) or PKR (Figure 1) in response to a range of stresses and signals (Koritzinsky et al., 2013; Muaddi et al., 2010; Wang and Kaufman, 2014) converts eIF2α from a substrate of the eIF2B g…”
Background
Cited by
Non-genetic mechanisms of therapeutic resistance in cancer
Marine, J.-C., Dawson, S.-J., & Dawson, M. A. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-020-00302-4 · Cited by 635
Melanoma plasticity and phenotypic diversity: therapeutic barriers and opportunities
Rambow, F., Marine, J.-C., & Goding, C. R. (2019) · Genes & Development · doi:10.1101/gad.329771.119 · Cited by 325
Self-citationRho GTPase signaling in cancer progression and dissemination
Crosas-Molist, E., Samain, R., Kohlhammer, L., Orgaz, J. L., George, S. L., Maiques, O., Barcelo, J., & Sanz-Moreno, V. (2022) · Physiological Reviews · doi:10.1152/physrev.00045.2020 · Cited by 272
Steps in metastasis: an updated review
Majidpoor, J., & Mortezaee, K. (2021) · Medical Oncology · doi:10.1007/s12032-020-01447-w · Cited by 264
Sublethal cytochrome c release generates drug-tolerant persister cells
Kalkavan, H., Chen, M. J., Crawford, J. C., Quarato, G., Fitzgerald, P., Tait, S. W. G., Goding, C. R., & Green, D. R. (2022) · Cell · doi:10.1016/j.cell.2022.07.025 · Cited by 255
Self-citation
Metadata
- Authors
- García-Jiménez, C., & Goding, C. R.
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2019-02
- Volume
- 29
- Issue
- 2
- Pages
- 254-267
- ISSN
- 1550-4131 (ISSN-L)
- OpenAlex
- W2906490108
- Cited by
- 150
- References
- 64
- FWCI
- 4.39
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.